22 February 2018
News and Views
Links and Services
A study in October's issue of the Alimentary Pharmacology & Therapeutics examines the efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients.
Crohn's disease recurs in the majority of patients after intestinal resection.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors